{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:19:33Z","timestamp":1794856773387,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["13N12530"],"award-info":[{"award-number":["13N12530"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijpharm.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T04:11:20Z","timestamp":1470802280000},"page":"994-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond"],"prefix":"10.1016","volume":"511","author":[{"given":"Nazende","family":"G\u00fcnday T\u00fcreli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif E.","family":"T\u00fcreli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9260-7357","authenticated-orcid":false,"given":"Marc","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.08.004_bib0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100102197","article-title":"Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method","volume":"25","author":"Barichello","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2004.09.011","article-title":"Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles","volume":"24","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0015","unstructured":"Clinical and Laboratory Standards Institute, 2006. Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard\u2014Ninth Edition. Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania, 19087-1898, USA."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2008.09.073","article-title":"A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles","volume":"133","author":"Cohen-Sela","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2004.01.033","article-title":"Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles","volume":"275","author":"Dillen","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2147\/IJN.S18905","article-title":"Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents","volume":"6","author":"Dinarvand","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0040","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/AAC.41.9.1996","article-title":"Structure-absorption relationships of a series of 6-fluoroquinolones","volume":"41","author":"Escribano","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0045","unstructured":"Ciprofloxacin (Ciprofloxacinum) Monograph (01089), 8.4 ed. European Pharmacopoeia 8.0."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.nano.2015.03.002","article-title":"Advances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regeneration","volume":"11","author":"Gainza","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-2275(20)38723-X","article-title":"Relation of lung fatty acid binding protein to the biosynthesis of pulmonary phosphatidic acid and phosphatidylcholine","volume":"28","author":"Haq","year":"1987","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050713","article-title":"Antibacterial activity of ciprofloxacin-encapsulated cockle shells calcium carbonate (aragonite) nanoparticles and its biocompatability in macrophage J774A.1","volume":"17","author":"Isa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(97)00163-6","article-title":"Clonazepam release from core-shell type nanoparticles in vitro","volume":"51","author":"Jeong","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0075","doi-asserted-by":"crossref","DOI":"10.3109\/21691401.2014.962745","article-title":"A review of emerging trends in the treatment of tuberculosis","volume":"44","author":"Kaur","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.drudis.2014.09.020","article-title":"Recent advances in controlled pulmonary drug delivery","volume":"20","author":"Liang","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0085","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/138955713804484721","article-title":"Functional PLGA NPs for oral drug delivery: recent strategies and developments","volume":"13","author":"Martin-Banderas","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2015.01.021","article-title":"Lipid prodrug nanocarriers in cancer therapy","volume":"208","author":"Mura","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0100","doi-asserted-by":"crossref","first-page":"15937","DOI":"10.1021\/la3033435","article-title":"In situ precipitation of amorphous calcium phosphate and ciprofloxacin crystals during the formation of chitosan hydrogels and its application for drug delivery purposes","volume":"28","author":"Nardecchia","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0142-9612(95)93575-X","article-title":"Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition","volume":"16","author":"Park","year":"1995","journal-title":"Biomaterials"},{"issue":"Suppl. 3","key":"10.1016\/j.ijpharm.2016.08.004_bib0110","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","article-title":"Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin. Infect. Dis.: Off. Pub. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpb.2006.06.009","article-title":"Effect of drug type on the degradation rate of PLGA matrices","volume":"64","author":"Siegel","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0130","series-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2009"},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0135","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2174\/0929867311320170006","article-title":"Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier","volume":"20","author":"Tosi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.2042-7158.2012.01486.x","article-title":"Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises","volume":"64","author":"Ungaro","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2013.08.079","article-title":"Nanocarriers for intravenous injection\u2014the long hard road to the market","volume":"457","author":"Wacker","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1023\/A:1018910431216","article-title":"The effect of temperature and pH on the solubility of quinolone compounds: estimation of heat of fusion","volume":"11","author":"Yu","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0155","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ces.2010.08.039","article-title":"Nanoparticle synthesis in microreactors","volume":"66","author":"Zhao","year":"2011","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ijpharm.2016.08.004_bib0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","article-title":"Effect of acidic pH on PLGA microsphere degradation and release","volume":"122","author":"Zolnik","year":"2007","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316307335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316307335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T02:24:18Z","timestamp":1656642258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316307335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0378517316307335"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.004","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}